Pulvino et al. demonstrated that inhibition of ubiquitin-conjugating (E2) enzyme Ubc13-Uev1A inhibits the proliferation and survival of DLBCL cells [33]. The gene discussed is UBE2V1; the disease is diffuse large B-cell lymphoma.